In the injected p53/Brca1 mice, we found that ~half of them developed various endometrial malignancies, including the hyperplasia of endometrial cells (Figure 4A), endometrial adenocarcinoma (Figure 4B), and leiomyosarcoma (Figure 4C). This evidence concerns the gene TP53 and leiomyosarcoma.